---
document_datetime: 2023-09-21 21:46:07
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/miglustat-genorph-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: miglustat-genorph-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.076973
conversion_datetime: 2025-12-27 17:15:09.732424
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Miglustat Gen.Orph

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                  |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0024              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 13/03/2023                          |                                             | SmPC and PL                      | To update section 4.4, 4.6 and 5.3 in order to improve clarity following assessment of same changes for reference product. Package leaflet has been updated accordingly. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| II/0023     | Please refer to the Recommendations section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 09/02/2023   | n/a        |                                  | Not applicable                                                                                                                                                                                                                                                                   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0022      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 21/07/2022   | 19/09/2022 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Miglustat Gen.Orph in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IB/0021     | B.II.e.1.b.1 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Solid, semi-solid and non-sterile liquid pharmaceutical forms                                                                                                                                                                                                                                                                                                                                                            | 11/01/2022   | 19/09/2022 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                  |
| IAIN/0020/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site | 01/12/2021   | 19/09/2022 | Annex II and PL                  |                                                                                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

| II/0018   | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                  | 02/09/2021   | n/a   |                     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|---------------------|
|           | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.b.z - Change in control of the AS - Other                                                                                                      | 27/08/2021   | n/a   | IB/0017/G variation |
| IB/0019   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                   | 12/08/2021   | n/a   |                     |
| IB/0016   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                       | 28/01/2021   | n/a   |                     |
| IA/0015/G | This was an application for a group of variations. B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer | 18/12/2020   | n/a   |                     |

<div style=\"page-break-after: always\"></div>

|           | B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer   |            |     |                  |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------|
| II/0013   | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                | 29/10/2020 | n/a |                  |
|           | This was an application for a group of variations. B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                   | 07/10/2020 | n/a | IB/0014/G        |
| IA/0012/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.3.a - Change in batch size (including batch size intermediate - Up to 10-fold          | 29/07/2020 | n/a | ranges) of AS or |

<div style=\"page-break-after: always\"></div>

|           | compared to the originally approved batch                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |    | increase size     |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-------------------|
| N/0011    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                           | 28/05/2020 | 19/09/2022 | PL |                   |
| IB/0010/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or novel excipient | 08/04/2020 | n/a        |    | manufacturer of a |
| N/0009    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                           | 03/03/2020 | 28/04/2020 | PL |                   |
| IA/0008   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                       | 12/12/2019 | n/a        |    |                   |
| IA/0007   | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                                                                                                                                                                                                                 | 02/10/2019 | n/a        |    |                   |
| II/0003   | B.I.a.1.b - Change in the manufacturer of AS or of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 04/07/2019 | n/a        |    |                   |

<div style=\"page-break-after: always\"></div>

|           | starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF                                                                                                                                        |            |            |                        |         |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------|
| IB/0006   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                            | 22/05/2019 | 28/04/2020 | SmPC                   |         |
| IB/0005   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 26/03/2019 | 29/04/2019 | SmPC, Labelling and PL | the MAH |
| N/0002    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                     | 02/05/2018 | 25/02/2019 | Labelling and PL       |         |
| IAIN/0001 | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                           | 02/03/2018 | 25/02/2019 | SmPC, Labelling and PL |         |